Featured Posts
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
National Review
Telehealth Is Less Promising Than It First Seemed
A key issue facing Congress in its postelection, “lame duck” session is whether to extend regulatory flexibilities expiring at year end that make telehealth services more…
Search Posts
Op-Eds
How To Create Shortages In An Abundant World
An old cold war joke asks a Russian, a Pole, an Israeli, and an American the following man-on-the-street question. “Excuse me, what is your opinion…
Breitbart
Breathless: FDA Bans Asthma Medication
Remember when Barack Obama – with the dignity and off-prompter grace, evincing deep understanding of the issues and the eloquence for which he is fawned…
Washington Times
Questionable Motives Behind Supplement Bill
Washington Times
Medical Magellans
Food and Drug Administration (FDA) rules are supposedly intended to ensure the safety and efficacy of new drugs and medical devices. It is FDA’s technology…
Products
Gregory Conko Discussing Cloning Translating Into Big Business and Safety Issues on CNNfn
CNNfn: Money & Markets (c) 2003 Federal Document Clearing House. All Rights Reserved. Friday, October 31, 2003 Business Cloning Translating Into Big Business and Safety…
Study
Safety, risk and the precautionary principle: rethinking precautionary approaches to the regulation of transgenic plants
Full Document Available in PDF Ever since completion of the Cartagena Protocol on Biosafety in…